A raging bull market for biotech stocks and a good story have transformed an ineffective weight loss drug into a Wall Street ...

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference.

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

Federal health officials expanded an infant botulism outbreak tied to recalled ByHeart baby formula to include all illnesses ...

Health system lawyers are silent on why hospitals don't keep AI scribe transcripts for quality and accuracy research.

High costs, quiet-period rules, investor skepticism, and lingering safety concerns are pushing major insurers to once again ...

Deputy health secretary Jim O’Neill demurred when asked about a proposal to prevent states from enforcing local AI laws.

In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...

The rise of anti-science and anti-vaccine rhetoric has fundamentally changed the relationship between clinicians and patients.” ...